KALYNNE BOYLES: Open Payments
NPI 1831868967 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 21 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $161 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Novo Nordisk Inc | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Lilly USA, LLC | 2 | $30 |
| PFIZER INC. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $26 |
| Exact Sciences Corporation | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
Products named: JARDIANCE, Ozempic, BREZTRI, DUPIXENT, CAPVAXIVE, PREVNAR 20, Veozah, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
